Nearly half of advanced ovarian cancer patients relapsed after first-line PARP inhibitor maintenance, emphasizing the need for refined postrecurrence strategies. BRCA mutation carriers were more ...
Rethinking breast cancer surveillance in women with BRCA-associated ovarian cancer in the post-solo trial era. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...
For most women, the body begins to change dramatically in their 40s or 50s. This transition, known as menopause, is defined as 12 consecutive months without a menstrual period, marking the end of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results